chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; This spontaneous case was reported by a consumer and describes the occurrence of   in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.   This case was linked to MOD-2021-026080 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021 , Containing Non-significant follow-up appended
A mother reported that her 2 month old son, with a history of "reflux problems", received Prevnar, DTAP, Hib and IPV vaccines on 1/3/02. That same day, the infant developed an "increase in reflux which led to aspiration". Subsequently, the child was hospitalized with a dx of pneumonia. He was treated with amoxicillin. The mother stated that the physician feels the "reactions may be the result of an allergy to ingredients in any of the vaccines". Information regarding this event has been forwarded. The pt developed an aggravation of reflux and aspiration following receipt of a subsequent dose of Prevnar; see (HQ1403920MAR2002).
high fevers, cough , sore throat, lethargy starting 2-3 days post vacc, persisting 3 + days
I was pregnant when I received the first two doses of the vaccine, then a little over a month after my baby was born I received a booster. All were in my right arm. I breast fed and during the first 5 months of my babies life I had mastitis 3 times in the right breast. Each time it was treated with antibiotics (not always the same antibiotic).
Shoulder Injury Related to Vaccine Administration (SIRVA).  The Nurse Practitioner administered the shot too high on my arm, up near the shoulder.  As a result, the shot was injected in or near the bursa, causing extreme pain, limited range of motion, and potentially long term damage.  I was diagnosed with Bursitis in the hospital two days later following a CT scan.  It does not appear the standard "two finger width" approach was followed to ensure injection into the deltoid muscle.  I am still in chronic pain.  I've received tramadol, percocet, and a corticosteroid injection.  I have a consultation with an orthopedic surgeon next week.  My shoulder was fine prior to the administration of the second vaccine, which seems to be due to poor technique by the nurse practitioner who administered it.
Was in bed for two days post-vaccination (starting the day after vaccination).; Patient reported flu-like symptoms; Felt feverish, hot and then cold/feels sometimes feverish; Felt feverish, hot and then cold.; Foggy thinking.; Headache; muscle aches; nausea.; Arm hurts at site of injection and is swollen; Arm hurts at site of injection and is swollen; Arm still hurts/swollen/red,; Arm still hurts/swollen/red,; Arm still hurts/swollen/red; This is a spontaneous report from a contactable consumer. This consumer reported for a 54-year-old non-pregnant female consumer (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via intramuscular route of administration on 20May2021 (at 54-year-old), as dose 1, single for COVID-19 immunization. Patient had previously had COVID-19 but had reached outside the 3-month window to where they could receive the vaccine without worrying about antibody interference. The patient was not tested for COVID-19 since the vaccination. The patient's concomitant medications were not reported. It was mentioned that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received medications within 2 weeks of vaccinations, but reporter was unsure of medications. On 21May2021 at 06: 30 pm the patient was in bed for two days post-vaccination (starting the day after vaccination). Patient reported flu-like symptoms, felt feverish, hot and then cold, had foggy thinking, headache, muscle aches, fever, nausea. Her arm hurted at site of injection and was swollen. Her arm still hurts/swollen/red. No therapeutic measures were received. On 23May2021 the patient recovered.   No follow-up attempts were needed; information about lot/batch number could not be obtained.
Dizzy/faint feeling about 10 or 15 min. after injection,  Swelling/warm to the touch/red & sensitive hard area the size of about 3x2 in. (showed up the night of 10/20, and still there as of 10/21 afternoon)
Red rash and Hives to posterior chest bilaterally, both side of lower part of LLQ and RLQ of the  abdomen, both upper arms and right lower arms that developed next day (12/11/2021) after the booster dose of Pfizer. Booster dose was received on 12/10/2021.
Hip and back muscle pain; bedridden; nausea; Sore arm injection site ,could not lift arm; Swollen Throat; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever) and CHILLS (chills) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Swollen Throat), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm). On 07-Apr-2021, the patient experienced PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden) and NAUSEA (nausea). At the time of the report, PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 99.2 (High) 99.2. On 07-Apr-2021, Influenza A virus test: (Negative) Negative. On 07-Apr-2021, Influenza B virus test: (Negative) Negative. On 07-Apr-2021, Respiratory syncytial virus test: (Negative) Negative. On 07-Apr-2021, SARS-CoV-2 test: (Negative) Negative. On 07-Apr-2021, Streptococcus test: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Additional information received on 20-May-2021 contains no new information.
for a 30 hour period i had chills and a fever or 100 to 99.5. but it ended as fast as it started. i developed a red itchy rash  below the injection spot. it started out small and is now larger and feels warm to the touch. i am just using a topical cream on it. no doctor visit involved now or in the future.
About 6 hours post vax, the pt developed a fever. The fever responded to children's Motrin (Highest Temp was 100.7). This lasted over a period of 3 days. Fever would spike, then drop. Fluids and warm baths given. The pt's left leg had a red, hard bump about the size of two quarters. Leg was red and extremely swollen and tender for four days. Warm compresses were applied. The MD was notified with only a mild reaction.
Patient was given his first dose of the Covid-19  vaccine which was Pfizer, He was given his second dose as Moderna by  as well.
Arm sore; Shoulder sore; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) taken on an unknown date for an unknown indication. The patient previously received the first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the left arm on 12Mar2021 at 17:00 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, after the second vaccination, patient experienced arm and shoulder sore, and it's worse at night. Patient took tylenol or advil helps to reduce the pain but it's not going away. It had been almost a week since the second vaccination. No other side effects like chills, fever and other issues were not reported by patient. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received the treatment with tylenol or advil for the events. The clinical outcome of the events arm sore and shoulder sore was not recovered.   No follow-up attempts are needed. No further information is expected.
Patient received shots 06/30/2003 (DTaP #5:Right Leg, IPV #4:Right Leg Lower, MMR #2:Left Leg).  At the site of DTaP #5, there is a reaction golf ball size.
headache which lead to migraine. then severe night sweats and chills with hot flashes. bleeding gums with soreness in lower jaw and irregular periods.  absent mindedness/ cloudy mind. forgetfulness.
About 12 hours after getting the shot, my daughter spiked a high fever, about 103, and began to shake violently. She than began to projectile vomit. Since then she has continues to run a high fever and vomit if she consumes anything, even water.
Information has been received from a doctor of pharmacy concerning a female in her sixties who on 22-JUN-2006 was vaccinated intramuscularly with a 0.5 mL second dose of Pneumovax 23. Within 4 hours of vaccination, the patient returned to the clinic. The patient's arm was painful, pink colored, swollen, warm to touch with a round circumscribed area 7-8 cm of deltoid. The patient was treated with an unspecified oral steroid. At the time of this report, the patient had not recovered. The PharmD. indicated that she had reported all of the information that she had concerning the patient's experience. No additional information is expected.
Patient was  being observed after vaccine and passed out. While laying on the floor, he seized x 2 for about 45 seconds.  No memory of seizure/seizure-like activity.
Rash - abdomen/trunk. Dots w/fluid, now scabbed over. Reaction to vaccine.
Pt received full vaccination series for the Moderna COVID-19 vaccine.  Pt subsequently still became ill with covid and needed treatment.  She began having symptoms of COVID on 9/9/2021 and tested positive for the virus on 9/13/2021.  Pt presented 9/16/2021 to outside ED, transferred here due to lack of closer facilities that could both treat COVID and had inpatient dialysis.  Discharged from this hospital on 9/22/2021.
ran temp on 17JUL (100.6 ax), had runny nose, grunting resp; few papules noted on forehead, & 1 leg; treated for bilateral ear infection;
This spontaneous report as received from a medical assistant refers to a 4 year old patient of unknown gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 30-SEP-2016, the patient received improperly stored doses of PROQUAD (lot # M010478 with expiration date 01-SEP-2017, therapy type HSA; dose, route of administration and anatomical location were not reported). It was reported that the PROQUAD was improperly stored at -3.5 Celsius for 1 hour and 6 minutes. There was no previous temperature excursion. Data logger was involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information is not expected as all relevant information has been received.; Sender's Comments: US-009507513-1610USA011245:
1st dose had injection site reaction that lasted 1 week, mild headache and mild muscle aches fatigue that lasted less than 8 hrs.  2nd dose had muscles aches, chills, nausea/vomiting, fever up to 101.5 F lasted 24 hours
Experienced bad cold sweats; A spontaneous report was received from a consumer concerning herself, a female patient of an unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bad cold sweats.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Feb 2021, prior to the onset of the events the patient received the first of two planned doses of mRNA-1273 (lot/batch: 010m20a) via unknown route for prophylaxis of COVID-19 infection.  On 15 Feb 2021 at night, the patient experienced bad cold sweats. The patient felt fine in the morning.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.    The outcome of event, bad cold sweats, was considered as resolved on 16 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I (patient) immediately experienced a burning sensation in my head.  I also felt off balance and wobbly.  The nurse checked my BP and it was  elevated  I believe  it was 150/90. Approximately.  The nurse had me wait for 20 mins and rechecked BP and it did come down.  That evening I experienced flu like symptoms   And the burning sensations countinuted through out my body over next 24 hrs.  Also extreme headaches.  By Sunday felt better but noticed the headaches were getting much more severe and my balance was off.  On Monday I decided to check my BP and it was 200/100. I immediately contacted my DR? they had me add a 25 mg Metoporal for one day.  In a nutshell for approximately 2 weeks my BP was extremely high.  Saw the DR after week one and in the office it was closer to normal 140/85.  When I showed the DR my readings they were much higher and she felt at that point it was an allergic reaction and I shouldn?t take 2nd dose.  My BP continued to trend downwards over the second week following and I finally received a normal reading 5/20th.  During the week following the vaccine my headache was debilitating?. I was laying down with cold compresses and taking Tylenol but it only curbed the headache pain?. My main issue was the elevated BP and interestingly enough, my sister had same reaction after  her second dose and endedup in the ER.
No adverse event; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 07-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication provided. No treatment information mentioned.  Patient took second dose of vaccine earlier than expected time gap for dose of vaccine. On unknown dates had reactions to vaccine. Felt bad, run down and tired, belt buckle area had a plaque psoriasis attack and sore arm. Later on unknown dates, sore arm, felt run down and felt bad resolved.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in   This case was linked to MOD-2022-619219 (Patient Link).
18 year old patient received an adult (1ml) dose of Engerix in July 2023; 18 year old patient received an adult (1ml) dose of Engerix in July 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 18-year-old patient who received HBV (Engerix B adult) for prophylaxis.   In JUL-2023, the patient received the 1st dose of Engerix B adult 1 ml. In JUL-2023, an unknown time after receiving Engerix B adult, the patient experienced overdose (Verbatim: 18 year old patient received an adult (1ml) dose of Engerix in July 2023) and adult product administered to child (Verbatim: 18 year old patient received an adult (1ml) dose of Engerix in July 2023).  The outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK receipt date: 25-Aug-2023 A pharmacist did not had patient or vaccination details, other than the 1st dose was given sometime in July. No symptoms were reported. The vaccine administration facility was the same as primary reporter. Did not consent to follow-up. An 18 year old patient received an adult dose of Engerix-B, which led to overdose and adult product administered to child.
Pt exp fever & generalized edema w/in 12 hrs p/DTP/OPV/HIB; no Resp sx or hives; Seen in office following day, had fever of 101.4 but no edema witnessed by medical personnel; Pt asympotomatic @ time of this report;
Extreme lethargy.  I was unable to get out of bed for longer than it took to use the restroom.  Headache.  Soreness all over the body.
Pt c/o pain in right deltoid area where Pneumovax vaccine was administered rated 10/10. Temp = 100.1 tympanic, 99.0 Temporal. Area was hard, slightly swollen and redden. Very tender to touch. Area was circled by staff. Pt offered ice but refused. Tylenol, Ibuprofen and Vistaril provided. Later that afternoon, the area on right shoulder much improved. It was dime sized with mild redness and some edema.
This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced injection site pain, injection site warmth, injection site erythema, shingles and blister. On an unknown date, the outcome of the injection site pain, injection site warmth, injection site erythema, shingles and blister were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site warmth, injection site erythema, shingles and blister to be related to SHINGRIX. Additional details were provided as follows: The caller was a GSK account manager reporting an adverse event that was reported to her by a health care professional. The age at vaccination was not reported, but the patient could be 59 or 60 years old at the time of reporting. The patient experienced pain, warmness, and redness at the injection site after receiving the 1st dose of SHINGRIX. Three weeks after receiving the vaccine, the patient developed a mild patch of shingles on her shoulder. There was no itching or pain, however, the patch did blister. The patch lasted for 7 to 10 days before going away. The caller did not have any additional information.
Flu like achy headache sick to stomach weak for 3 days. After that developed a rash with bumps. Some bumps had tiny blisters. They would flake away and reform. On left side of forehead. After a month it moved down to eye level on same side face and over to eye lid. Contacted my Dr. received Valacyclovir 3 times a day for 7 days. Symptoms disappeared after that.
Sore arm within a couple of hours. Woke up next morning feeling tired and stiff. Temperature was 100. Temperature climbed to 101 by 2pm.
Headache, Myalgia, Fever, Chills, body aches, sweats, fatigue Narrative: Body aches, fever of 100.3, chills, sweats, headache, fatigue lasted 24 hours followed by feeling weak the next day. Itching at the injection site 10 days later
None stated.   7/7/09 Medical records received DOS 12/26/07 to 6/23/09. Assessment: Rash Patient presented with erythematous maculopapular rash all over body. Fussy last night. Diarrhea, vomiting. Bite mark.
ED visit for left ureteral stone. Prescribed short course of Norco, Zofran, and Flomax. Referral placed to urology for follow-up. This visit was within 6 weeks of receiving the COVD vaccine.
Office Visit 5/4/2021 Urgent Care -    Family Medicine Suspected COVID-19 virus infection Dx Nasal Congestion  Reason for Visit Progress Notes (Nurse Practitioner) ? ? Family Medicine ? ? Encounter Date: 5/4/2021 ? ? Signed Expand All Collapse All    MDM    1. Suspected COVID-19 virus infection  a 41 y.o. female Presents with nasal congestion for the past 3 days.  She reports losing her taste today.  Reported fevers.  No headache or dizziness.  No chest pain shortness of breath.  Son with similar symptoms and was also tested for Covid.   At this time, pt will be swabbed for COVID 19 - pt verbalized understanding related to strict quarantine recommendations until results have been obtained and management. Pt verbalized understanding related to close follow up recommendations. Work note given. Pt left in stable conditions.
red, sore, swollen upper lt arm;onset 9/9/99 w/complaint of red, swollen @ site;allerg react;to MD;also said allerg rxn, diff urinating, face tingling, sweating, dec appetite;dx allerg rxn;advised never to take again;medrol, claritin;
16 y.o female with history of anxiety depression was brought to the ED because she became talkative, acting agitated.  She developed some achiness, couldn't do her daily exercises and became agitated.  She is apparently on some antidepressant medications. There are no suicidal/homocidal ideations.  No voices. This episode resolved about 12-18 hours after the injections were given. Temp was 100.8 in the ED. Had been given some tylenol.